Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone

被引:84
作者
Nilsson, KO
AlbertssonWikland, K
Alm, J
Aronson, S
Gustafsson, J
Hagenas, L
Hager, A
Ivarsson, SA
Karlberg, J
Kristrom, B
Marcus, C
Moell, C
Ritzen, M
Tuvemo, T
Wattsgard, C
Westgren, U
Westphal, O
Aman, J
机构
[1] UNIV HOSP, DEPT DIAGNOST RADIOL, S-21401 MALMO, SWEDEN
[2] GOTHENBURG UNIV, DEPT PEDIAT, S-41124 GOTHENBURG, SWEDEN
[3] LINKOPING UNIV, DEPT PEDIAT, LINKOPING, SWEDEN
[4] UMEA UNIV, DEPT PEDIAT, UMEA, SWEDEN
[5] UNIV UPPSALA, DEPT PEDIAT, UPPSALA, SWEDEN
[6] KAROLINSKA HOSP, DEPT PEDIAT, S-10401 STOCKHOLM, SWEDEN
[7] HUDDINGE HOSP, STOCKHOLM, SWEDEN
[8] CENT HOSP HALMSTAD, DEPT PEDIAT, HALMSTAD, SWEDEN
[9] CENT HOSP, DEPT PEDIAT, OREBRO, SWEDEN
[10] UNIV HONG KONG, QUEEN MARY HOSP, DEPT PEDIAT, HONG KONG, HONG KONG
关键词
D O I
10.1210/jc.81.2.635
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The spontaneous growth process in Turner's syndrome is characterized by a progressive decline in height velocity during childhood and no pubertal growth spurt. Therefore, therapy aimed at improving height during childhood as well as increasing final height is desirable for most girls with Turner's syndrome. Forty-five girls with Turner's syndrome, 9-16 yr of age (mean age, 12.2 yr), were allocated to three study groups. Group 1 (n = 13) was initially treated with oxandrolone alone; after 1 yr of treatment, GH without (group 1a; n = 6) or with (group 1b; n = 7) ethinyl estradiol was added. Group 2 (n = 17) was treated with GH plus oxandrolone. Group 3 (n = 15) was treated with GH, oxandrolone, and ethinyl estradiol. The dosages were: GH, 0.1 IU/kg . day; oxandrolone, 0.05 mg/kg . day; and ethinyl estradiol, 100 ng/kg . day. A height of 150 cm or more was achieved in 61%, 75%, and 60% of the girls in groups 1, 2, and 3, respectively. The most impressive increase in height was seen in group 2. In this group the mean final height was 154.2 cm (SD = 6.6), which is equivalent to a mean net gain of 8.5 cm (SD = 4.6) over the projected final height. In group 3, in which ethinyl estradiol was included from the start of therapy, the initially good height velocity decelerated after 1-2 yr of treatment. Their mean final height was 151.1 (SD = 4.6) cm, equivalent to a mean net gain of 3.0 cm (SD = 3.8). A similar growth-decelerating effect of ethinyl estradiol was seen in group 1b. We conclude that in girls with Turner's syndrome who are older than 9 yr of age, treatment with GH in combination with oxandrolone results in significant growth acceleration, imitating that in normal puberty, leading to a more favorable height during childhood. This mode of treatment also results in a significantly increased final height, permitting a great number of the girls to attain a final height of more than 150 cm. However, early addition of estrogen decelerates the height velocity and reduces the gain in height.
引用
收藏
页码:635 / 640
页数:6
相关论文
共 31 条
[1]  
ABRAHAM GE, 1975, OBSTET GYNECOL, V45, P271
[2]  
ALBERTSSONWIKLAND K, 1991, INT CONGR SER, V924, P23
[4]   SUBNORMAL PUBERTAL INCREASES OF SERUM ANDROGENS IN TURNERS SYNDROME [J].
APTER, D ;
LENKO, HL ;
PERHEENTUPA, J ;
SODERHOLM, A ;
VIHKO, R .
HORMONE RESEARCH, 1982, 16 (03) :164-173
[5]  
BAINBRIDGE JWB, 1991, INT CONGR SER, V924, P159
[6]   CIRCULATING GROWTH-HORMONE ISOFORMS IN GIRLS WITH TURNERS-SYNDROME [J].
BLETHEN, SL ;
ALBERTSSONWIKLAND, K ;
FAKLIS, EJ ;
CHASALOW, FI .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (06) :1439-1443
[7]  
Greulich W.W., 1971, RADIOGRAPHIC ATLAS S
[8]  
HOCHBERG Z, 1993, INT CONGR SER, V1014, P233
[9]   OXANDROLONE IN GIRLS WITH TURNERS SYNDROME - A PAIR-MATCHED CONTROLLED-STUDY UP TO FINAL HEIGHT [J].
JOSS, E ;
ZUPPINGER, K .
ACTA PAEDIATRICA SCANDINAVICA, 1984, 73 (05) :674-679
[10]  
KARLBERG J, 1989, ACTA PAEDIATR SCAND, P26